Theresa Heggie, a director at BioCryst Pharmaceuticals Inc. (BCRX), sold BCRX shares once on the open market in the last year for a total of nearly $596,000. Her most recent sale occurred on August 13, 2025. These sales rank her 6,086th among 11,678 individual insiders by value sold, below the average of about $8.6 million per insider and 6.4 transactions. Heggie made no open market purchases of BCRX shares in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | M | Common Stock | 49933 | $6.30 | 115,285.0000 | 219,885,000 | 76.41% | 0.02% |
| March 20, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | S | Common Stock | 49933 | $10.11 | 65,352.0000 | 219,885,000 | 43.31% | 0.02% |
| March 20, 2026 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | M | Automatic Stock Option Grant | 49933 | $0.00 | 0.0000 | 219,885,000 | 100.00% | 0.02% |
| Aug. 13, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | M | Automatic Stock Option Grant | 40000 | $0.00 | 0.0000 | 206,696,000 | 100.00% | 0.02% |
| Aug. 13, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | M | Common Stock | 40000 | $5.41 | 135,352.0000 | 206,696,000 | 41.95% | 0.02% |
| Aug. 13, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | S | Common Stock | 70000 | $8.51 | 65,352.0000 | 206,696,000 | 51.72% | 0.03% |
| Aug. 13, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | M | Automatic Stock Option Grant | 30000 | $0.00 | 0.0000 | 206,696,000 | 100.00% | 0.01% |
| Aug. 13, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | M | Common Stock | 30000 | $2.91 | 95,352.0000 | 206,696,000 | 45.91% | 0.01% |
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Common Stock | 12500 | $0.00 | 65,352.0000 | 206,696,000 | 23.65% | 0.01% |
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Automatic Stock Option Grant | 27181 | $0.00 | 27,181.0000 | 206,696,000 | 9999.99% | 0.01% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Common Stock | 6820 | $0.00 | 59,550.0000 | 192,198,000 | 12.93% | 0.00% |
| June 14, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | S | Common Stock | 6698 | $6.11 | 52,852.0000 | 192,198,000 | 11.25% | 0.00% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Automatic Stock Option Grant | 49933 | $0.00 | 49,933.0000 | 192,198,000 | 9999.99% | 0.03% |
| May 31, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Common Stock | 870 | $6.46 | 52,730.0000 | 192,198,000 | 1.68% | 0.00% |
| Feb. 29, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Common Stock | 999 | $5.63 | 51,860.0000 | 192,198,000 | 1.96% | 0.00% |
| Nov. 30, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Common Stock | 956 | $5.88 | 50,861.0000 | 185,908,000 | 1.92% | 0.00% |
| Aug. 31, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Common Stock | 791 | $7.11 | 49,905.0000 | 185,908,000 | 1.61% | 0.00% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Automatic Stock Option Grant | 39072 | $0.00 | 39,072.0000 | 185,908,000 | 9999.99% | 0.02% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Common Stock | 16745 | $0.00 | 49,114.0000 | 185,908,000 | 51.73% | 0.01% |
| May 31, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Common Stock | 680 | $8.27 | 32,369.0000 | 185,908,000 | 2.15% | 0.00% |
| Feb. 28, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | HEGGIE THERESA | Director | A | Common Stock | 635 | $8.85 | 31,689.0000 | 185,908,000 | 2.04% | 0.00% |